Skip to main content
42°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
99
100
Next >
Actinium Pharmaceuticals Receives FDA Request For Additional Studies On Leukemia Treatment
August 05, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ATNM
FDA Panel Backs Zevra's Arimoclomol For Rare Genetic Disorder, Analyst Highlights Balanced Portfolio Of Marketed Products And Pipeline Assets Focused On Rare Diseases
August 05, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ZVRA
EXCLUSIVE: Alzamend Neuro To Assess AL001 Alzheimer's Candidate Against Commonly Marketed Lithium Salt In Phase 2 Head-To-Head Study
August 05, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ALZN
Mental Health Watchdog Urges FDA to Ban Electroshock Device
August 05, 2024
Via
Press Release Distribution Service
Exposures
Product Safety
Intelligent Bio Solutions Inc. (Nasdaq: INBS) Announces Major Steps Towards FDA Clearance and U.S. Launch.
August 02, 2024
Via
AB Newswire
Exposures
Product Safety
Tickers
INBS
MDC Associates Combines IVD Expertise with CRO Services Excellence at ADLM 2024
July 30, 2024
Via
Press Release Distribution Service
Exposures
Product Safety
Lucid Stock Warning: LCID Offers Little Upside Ahead. Steer Clear.
August 02, 2024
Via
InvestorPlace
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
LCID
TSLA
BioMedNewsBreaks — CEL-SCI Corp. (NYSE American: CVM) Closes on $10.8M Best-Efforts Offering
August 02, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CVM
FDA Approves Adaptimmune Therapeutics' Engineered Cell Therapy As First For Solid Tumor And New Therapy For Rare Soft Tissue Cancer In Over A Decade
August 02, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ADAP
GLPG
Boar’s Head Recalls 2024: 7 Million Pounds of Deli Meat, Poultry Pulled
July 31, 2024
Via
InvestorPlace
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
FFIE
INTC
SAVE
Ground Cinnamon Recalls: What to Know as FDA Issues Alert Over Lead Levels
July 31, 2024
Via
InvestorPlace
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
ASML
FGEN
Zynex Inc. CEO Thomas Sandgaard Discusses Significant Company Growth and Future Innovations
July 31, 2024
Via
News Direct
Exposures
Product Safety
Mainz Biomed's (NASDAQ: MYNZ) Cutting-Edge Colorectal Cancer Test Applies For FDA Breakthrough Status
July 31, 2024
Via
News Direct
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Tickers
MYNZ
E-Commerce Giant Amazon Ordered To Recall Over 400K Hazardous Products Sold On Its Site By US Federal Agency
July 31, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
AMZN
Alignment with FDA on Pediatric Study Plan and Accelerated Approval to Treat Bipolar Depression and Akathisia: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
July 30, 2024
Via
Get News
Exposures
Product Safety
Tickers
NRXP
FDA Warns Of Overdose Risks With Compounded Wegovy, Ozempic Injections
July 30, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
NVO
Acarix announces shares are now being traded on the OTCQB under the ticker ACIXF
July 30, 2024
Via
News Direct
Exposures
Product Safety
Family Vision Optical Welcomes Dr. Amanda Bancroft to Their Eye Care Team
July 30, 2024
Via
Press Advantage
Topics
Product Recall
Exposures
Legal
Product Safety
TSLA Stock Drops as Tesla Recalls 1.8 Million EVs Over Hood Issue
July 30, 2024
Via
InvestorPlace
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
DAL
SA
SOFI
TSLA
InvestorNewsBreaks – Processa Pharmaceuticals Inc.’s (NASDAQ: PCSA) IND Application for Phase 2 Clinical Trial of NGC-Cap in Patients with Breast Cancer Receives FDA Clearance
July 30, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
PCSA
Movano Evie Ring Could Soon Get FDA Clearance, Analyst Says: 'A Validated Wearable Device Truly Opens The Market'
July 30, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
MOVE
Annovis Bio Inc. (NYSE: ANVS) Announces FDA Approval to Transition to New Form of Buntanetap for Future Clinical Trials
July 30, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
ANVS
Merck's Q2 Earnings: Revenue And EPS Beat Helped By Strong Keytruda Sales, But Acquisition Costs Bites Into Annual Profit Forecast
July 30, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
DSKYF
DSNKY
MRK
Tesla Recalls Over 1.8M Vehicles Over Concerns Of Unlatched Hood Opening When Driving
July 30, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
TSLA
Art Installation Near White House Urges FDA To Approve MDMA-Assisted Therapy For Veterans As Decision Time Looms
July 29, 2024
Via
Benzinga
Exposures
Product Safety
FDA Greenlights Guardant Health's Shield Blood Test, Analyst Cautious on Adoption
July 29, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
EXAS
GH
FDA Puts Brake On vTv Therapeutics' Diabetes Candidate Program, Including Late-Stage Study, Stock Tanks
July 29, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
VTVT
American Kratom Association Calls on the FDA To Be Fully Transparent and Accountable in Their Safety Alert on Kratom Products
July 29, 2024
Via
EZ Newswire
Exposures
Product Safety
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Lomecel-B(TM) Study Results Presented at the Alzheimer’s Association International Conference
July 29, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
LGVN
AGC Biologics’ Seattle Site Achieves Successful Multi-Product Inspection by U.S. Food and Drug Administration for Biologics License Applications
July 29, 2024
Via
News Direct
Exposures
Product Safety
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.